Aquedeon Medical

Executive Summary

Aquedeon Medical is a San Diego-based private medical device company founded in 2019 with the mission to reduce circulatory arrest time during open cardiothoracic surgery. Its flagship product, the Duett Vascular Graft System, is designed to standardize and simplify open surgical vascular procedures, potentially improving outcomes for patients undergoing complex cardiac and vascular surgeries. The company aims to provide cardiothoracic and vascular surgeons with a reliable tool that can streamline surgery and reduce complications associated with prolonged circulatory arrest. As a private company with limited public information, Aquedeon Medical appears to be in the early stages of development. No funding rounds or revenue data are available, suggesting the company may still be in preclinical or early clinical phases. The Duett Vascular Graft System addresses a clear clinical need, but regulatory and commercial milestones remain ahead. Given the competitive landscape for vascular grafts and the challenges of med-tech adoption, the company's long-term success will depend on successful clinical validation, regulatory clearance, and strategic partnerships.

Upcoming Catalysts (preview)

• Q2 2027FDA 510(k) Clearance for Duett Vascular Graft System25% success
• Q4 2026First-in-Human Study Results40% success
• Q1 2027Strategic Partnership or Investment30% success